» Articles » PMID: 22268679

Clozapine Inhibits Th1 Cell Differentiation and Causes the Suppression of IFN-γ Production in Peripheral Blood Mononuclear Cells

Overview
Publisher Informa Healthcare
Date 2012 Jan 25
PMID 22268679
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Antipsychotic drugs (APDs) are widely used to alleviate a number of psychic disorders and may have immunomodulatory effects. However, the previous studies of cytokine and immune regulation in APDs are quite inconsistent. The aim of this study was to examine the in vitro effects of different ADPs on cytokine production by peripheral blood mononuclear cells (PBMCs). We examined the effects of risperidone, clozapine, and haloperidol on the production of phorbol myristate acetate and ionomycin-induced interferon-γ (IFN-γ)/interleukin (IL)-4 in PBMCs by using intracellular staining. Real-time quantitative PCR and Western blot were used to further examine the expression changes of some critical transcription factors related to T-cell differentiation in antipsychotic-treated PBMCs. Our results indicated that clozapine can suppress the stimulated production of IFN-γ by 30.62%, whereas haloperidol weakly enhances the expression of IFN-γ. Differences in IL-4 production or in the number of CD4+ T cells were not observed in cells treated with different APDs. Furthermore, clozapine and risperidone inhibited the T-bet mRNA and protein expression, which are critical to Th1 differentiation. Also, clozapine can enhance the expression of Signal Transducer and Activator of Transcription 6 and GATA3, which are critical for the differentiation of Th2 cells. The results suggested that clozapine and haloperidol may induce different immunomodulatory effects on the immune system.

Citing Articles

Lights and shadows of clozapine on the immune system in schizophrenia: a narrative literature review.

Liu J, Zhao W, Wang Y Metab Brain Dis. 2025; 40(2):128.

PMID: 39954151 DOI: 10.1007/s11011-025-01558-1.


Vaccination and clozapine use: a systematic review and an analysis of the VAERS database.

Aksar A, Lutz J, Wagner E, Strube W, Luykx J, Hasan A Eur Arch Psychiatry Clin Neurosci. 2024; 275(1):141-162.

PMID: 38165458 DOI: 10.1007/s00406-023-01729-0.


The Impacts of Clozapine Use on the Risk and Outcomes of COVID-19 Disease in Patients with Schizophrenia.

Ozdemir M, Yildirim Y, Kart A Noro Psikiyatr Ars. 2023; 60(2):99-103.

PMID: 37287549 PMC: 10242284. DOI: 10.29399/npa.28317.


Canonical and Non-Canonical Antipsychotics' Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia.

de Bartolomeis A, Ciccarelli M, De Simone G, Mazza B, Barone A, Vellucci L Int J Mol Sci. 2023; 24(6).

PMID: 36983018 PMC: 10051989. DOI: 10.3390/ijms24065945.


The Role of Total White Blood Cell Count in Antipsychotic Treatment for Patients with Schizophrenia.

Zhang Y, Tao S, Coid J, Wei W, Wang Q, Yue W Curr Neuropharmacol. 2023; 22(1):159-167.

PMID: 36600620 PMC: 10716888. DOI: 10.2174/1570159X21666230104090046.